Showing 1401-1410 of 2166 results for "".
FDA Expands Product Label for Iluvien
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-expands-product-label-for-iluvien/37076/Iluvien receives a major label expansion; Bausch and Lomb launches a new orthokeratology lens fitting system; and several updates are announced in development wet AMD candidates. Learn more about your ad choices. Visit megaphone.fm/adchoicesFDA Approves First Treatment for MacTel
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-approves-first-treatment-for-mactel/37075/The CEO of Neurotech joins us to talk about the FDA approval of the first treatment for MacTel; a target action date is set for Sydnexis’ pediatric myopia treatment candidate; and three eye care companies collaborate to launch a wearable vision testing platform. Learn more about your ad choices. VisA New Approach to Treating Keratoconus
https://modernod.com/articles/significant-findings/a-new-approach-to-treating-keratoconus/37828/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatNew Myopia Software on Pentacam AXL
https://modernod.com/podcasts/eyewire-news-the-podcast/new-myopia-software-on-pentacam-axl/37073/Oculus launches new myopia software on its Pentacam AXL; the first clinical polygenic risk score test for glaucoma in the US is launched; and Virtual Vision Health releases visual acuity testing on its VR platform Learn more about your ad choices. Visit megaphone.fm/adchoicesExamining DED From a Different Perspective
https://modernod.com/topics/ocular-surface/examining-ded-from-a-different-perspective/38928/A research review of the condition’s nonocular impacts.Lessons From the Trauma Unit
https://modernod.com/topics/human-interest/lessons-from-the-trauma-unit/38926/Keep these tips in mind when dealing with ocular emergencies.Practical Insights on OCTA in Glaucoma
https://modernod.com/topics/glaucoma/practical-insights-on-octa-in-glaucoma/38924/Brush up on the use of this imaging modality in the management of glaucoma.Zeiss MEL 90 Approved by FDA
https://modernod.com/podcasts/eyewire-news-the-podcast/zeiss-mel-90-approved-by-fda/37068/Zeiss receives a major approval for its new excimer laser; Bausch + Lomb makes two deals to bolster its pipeline in glaucoma and geographic atrophy; and Rayner announces the full European launch of its RayOne Galaxy IOLs. Learn more about your ad choices. Visit megaphone.fm/adchoices2024 Year in Review — Part 2
https://modernod.com/podcasts/eyewire-news-the-podcast/2024-year-in-review-part-2/37065/In today’s episode, we review the top stories from the second half of 2024. The last six months saw the launch of first-of-its-kind IOLS; the clinical advancement of gene therapies for rare diseases; the FDA approval of a device to treat patients with dry AMD; and introduction of novel OCTA technolo2024 Year in Review — Part 1
https://modernod.com/podcasts/eyewire-news-the-podcast/2024-year-in-review-part-1/37064/In today’s broadcast, we look back at the top stories from the first half of 2024. There were several advancements made during the first six months., including the approval of an excimer laser platform; the global adoption of sustained-released anti-VEGF treatments for retinal diseases; the rollout